Records containing: Rheumatoid Arthritis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2021-01-26The Relation Between Macrophage Migration Inhibitory Factor (MIF) and 25(OH) Vitamin D3 Serum Levels in Rheumatoid Arthritis
-
CLINICAL_TRIALS study record update · 2021-01-19A Randomized, Double-blind, Placebo- and Active-controlled, Multicenter, Phase 3 Study to Assess the Efficacy and Safety of Filgotinib Administered for 52 Weeks in Combination With Methotrexate to Subjects With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
-
CLINICAL_TRIALS study record update · 2021-01-15A Phase 1 Open-Label Study to Evaluate the Pharmacokinetics of Filgotinib in Subjects With Impaired Hepatic Function
-
CLINICAL_TRIALS study record update · 2021-01-15Evaluation of Bone Quality in Patients With Rheumatoid Arthritis Treated With Baricitinib: Single Centre, Mode of Action Study (BARE BONE)
-
CLINICAL_TRIALS study record update · 2021-01-15Adenocorticotrophic Hormone for Acute Treatment of Rheumatoid Arthritis Patients With Inadequate Response to Methotrexate
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2021-01-15A Randomized, Double-blind, Placebo- and Active-controlled, Multicenter, Phase 3 Study to Assess the Efficacy and Safety of Filgotinib Administered for 52 Weeks Alone and in Combination With Methotrexate (MTX) to Subjects With Moderately to Severely Active Rheumatoid Arthritis Who Are Naïve to MTX Therapy
-
CLINICAL_TRIALS study record update · 2021-01-15A Randomized, Double-blind, Placebo-controlled, Multicenter, Phase 3 Study to Assess the Efficacy and Safety of Filgotinib Administered for 24 Weeks in Combination With Conventional Synthetic Disease-modifying Anti-rheumatic Drug(s) (csDMARDs) to Subjects With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Biologic DMARD(s) Treatment
-
CLINICAL_TRIALS study record update · 2021-01-11An Open-label, Multiple-dose Study to Assess the Pharmacokinetics, Pharmacodynamics, Preliminary Clinical Activity and Safety of Human Mouse Chimeric Anti-CD22 Monoclonal Antibody (SM03) in Patients With Rheumatoid Arthritis
-
CLINICAL_TRIALS study record update · 2021-01-08Vitamin D and Fish Oil for Autoimmune Disease, Inflammation and Knee Pain
-
CLINICAL_TRIALS study record update · 2021-01-07A Randomized, Open-Label, Parallel-Group, Single-dose, Biocomparability Study of the Pharmacokinetics of the Abatacept (BMS-188667) Drug Product Converted From Drug Substance of a New Abatacept Drug Substance Process Relative to the Current Abatacept Drug Process in Healthy Participants
-
CLINICAL_TRIALS study record update · 2021-01-07Association Between Long-term Hydroxychloroquine Treatment and Outcome of a History of Symptoms Suggestive of COVID-19 Infection During the Epidemic Period in France in Patients With Autoimmune Disease
-
CLINICAL_TRIALS study record update · 2021-01-05Effect of Laser Puncture on Rheumatoid Arthritis Patients
-
CLINICAL_TRIALS study record update · 2020-12-29Impact of the Rheumatoid Factor on Serological Testing Performance for Covid-19 in Rheumatoid Arthritis Patients
-
CLINICAL_TRIALS study record update · 2020-12-28Nerve Block of the Proximal Interphalyngeal Joints PIPs in Rheumatoid Arthritis (RA) Patients: a Prospective Pilot Study
-
CLINICAL_TRIALS study record update · 2020-12-22A Multi-center, Noninterventional Study With Certolizumab Pegol in Comparison With Any Other Subcutaneous TNF Inhibitor in Two Parallel Groups in Biologic Naive Patients With Rheumatoid Arthritis
-
CLINICAL_TRIALS study record update · 2020-12-21Prevalence, Seroconversion and Impact of COVID-19 in Autoimmune Diseases in Europe
-
CLINICAL_TRIALS study record update · 2020-12-19A Phase 3, Randomized, Double-Blind, Active- and Placebo-controlled, Parallel-group Trial to Evaluate the Efficacy and Safety of CF101 Compared to Methotrexate in the Treatment of Early Rheumatoid Arthritis
-
CLINICAL_TRIALS study record update · 2020-12-19Real-life Experience of Tofacitinib in Patients With Treatment-Resistant Rheumatoid Arthritis
-
CLINICAL_TRIALS study record update · 2020-12-19A Randomized Withdrawal Double-blind Study of Etanercept Monotherapy Compared to Methotrexate Monotherapy for Maintenance of Remission in Subjects With Rheumatoid Arthritis
-
CLINICAL_TRIALS study record update · 2020-12-17Post-Market Clinical Follow-Up (PMCF) Study of the CLS Brevius Stem With Kinectiv Technology
-
CLINICAL_TRIALS study record update · 2020-12-11A Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of VAY736 in Rheumatoid Arthritis Patients
-
CLINICAL_TRIALS study record update · 2020-12-11Psychological Impact of Quarantine in Rheumatoid Arthritis Patient During COVID-19 Outbreak
-
CLINICAL_TRIALS study record update · 2020-12-11A Randomized, Double-blind, Placebo-controlled, Single Ascending Dose First-in-human Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CFZ533 in Healthy Subjects and Rheumatoid Arthritis Patients
-
CLINICAL_TRIALS study record update · 2020-12-04A Randomized, Double-Blind, Parallel-Group, International Study to Evaluate the Safety and Efficacy of Ocrelizumab Given As a Single Infusion or Dual Infusion Compared With Placebo in Patients With Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate Therapy
-
CLINICAL_TRIALS study record update · 2020-12-03A Study to Assess Efficacy and Safety of Wangbi Capsule in Patients With Rheumatoid Arthritis